Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the epstein-barr virus-Reference-Cited by-同舟云学术

Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the epstein-barr virus

Published:1988-04-15 Issue:4 Volume:41 Page:479-482
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Uen Wu-Ching,Luka Janos,Pearson Gary R.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. An immunologic basis for detection of occult primary malignancies of the head and neck

2. and , Population screening for EBV markers: toward improvement of nasopharyngeal carcinoma control. In: and (eds.), The Epstein-Barr virus, recent advances, pp. 236–249, Heinemann, London (1986).

3. Increased incidence of IgA antibodies to the epstein-barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia

4. Detection of IgA antibodies to Epstein-Barr virus-associated antigens by ELISA

5. Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein–Barr virus dynamics and its prognostic impact on nasopharyngeal cancers in a non-endemic region;ecancermedicalscience;2022-12-02

2. Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy;Scientific Reports;2016-12

3. Prognostic Factors in Nasopharyngeal Cancer;Medical Radiology;2010

4. Salivary and serum IgA antibodies to the epstein-barr virus glycoprotein gp340: incidence and potential for virus neutralization;International Journal of Cancer;2007-07-05

5. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma;International Journal of Radiation Oncology*Biology*Physics;2007-01